SPIRO-2110

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameSPIRO-2110
Drug Alias NameSPIRO-2110
ClassificationBiologics
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulatorsGene transference
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSpirovant Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesSpirovant Sciences Inc
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A